On the prior authorization form your healthcare provider will confirm youve tried these options and need a stronger and more effective treatment for chronic weight management
Semaglutide should be discontinued at least 2 months before a planned pregnancy, as weight loss is not recommended during pregnancy
Follow-Up Appointments As mentioned, were here for you every step of the way, so youll need to return for follow-ups to monitor your progress, check for any adverse effects, provide continuous support as you lose weight, and adjust your dose as necessary
Our products Tirzepatide COA Tirzepatide,as the world's first dual GIP/GLP-1 receptor agonist, has swiftly emerged as a benchmark drug in the field of metabolic disease treatment since its injection formulation was approved by the US FDA in 2022
The findings were groundbreaking: participants receiving tirzepatide showcased substantial weight reductions compared to the placebo group